Finance

Lists
Outlook: 81.8% bullish·0.0% bearish
Go to analysis
AVBP:NASDAQ
Arrivent Biopharma Inc
15,95 $
+1,40%
(+0,22) 1D
15,77 $
-1,13% (-0,18)
Pre-market
Closed: 29 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVBP...
Open
15,87 $
High
16,42 $
Low
15,73 $
Mkt. cap
786,46 մլն
Avg. vol.
2,02 մլն
Volume
16,28 հզր
52-wk high
35,83 $
52-wk low
11,37 $
EPS
-3,67 $
Shares outstanding
49,31 մլն
No. of employees
77
Open
15,87 $
High
16,42 $
Low
15,73 $
Mkt. cap
786,46 մլն
Avg. vol.
2,02 մլն
Volume
16,28 հզր
52-wk high
35,83 $
52-wk low
11,37 $
EPS
-3,67 $
Shares outstanding
49,31 մլն
No. of employees
77
News stories
From web sources and news partners
About Arrivent Biopharma Inc
CEO-
Employees77
Founded2021
HeadquartersNewtown Square, Փենսիլվանիա, Միացյալ Նահանգներ
Sector-
Websitearrivent.com
Analyst ratings
Based on 12 analysts giving stock ratings to AVBP in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for AVBP in the last 3 months.
Highest
Current 15,95 $
45,00 $ (+182,13%)
Average
25,55 $ (+60,19%)
Lowest
15,00 $ (-5,96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
27,00 $
+69,3%
10/28/2026
Michael Schmidt
Guggenheim
Buy
Maintained
30,00 $
+88,1%
10/26/2026
Supawat Thongthip
Truist Financial
Buy
Reiterated
21,00 $
+31,7%
10/27/2026
Jeff Jones
Oppenheimer
Buy
Maintained
25,00 $
+56,7%
10/26/2026
Jeet Mukherjee
BTIG
Buy
Maintained
29,00 $
+81,8%
10/26/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
-
-
10/25/2026
Yigal Nochomovitz
Citi
Buy
Maintained
20,00 $
+25,4%
10/23/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
29,00 $
+81,8%
10/20/2026
Boris Peaker
JonesTrading
Buy
Reiterated
22,00 $
+37,9%
10/06/2026
Kelly Shi
Jefferies
Buy
Maintained
18,00 $
+12,9%
10/06/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
15,00 $
-6%
10/06/2026
Asthika Goonewardene
Leerink Partners
Buy
Maintained
45,00 $
+182,1%
08/13/2026
Soumit Roy
JonesTrading
Buy
Maintained
45,00 $
+182,1%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
32,17 մլն
32,18 մլն
37,62 մլն
42,34 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,15 մլն
6,65 մլն
8,49 մլն
10,35 մլն
Operating expense
38,32 մլն
38,82 մլն
46,11 մլն
52,69 մլն
Total operating expenses
38,32 մլն
38,82 մլն
46,11 մլն
52,69 մլն
Operating income
-38,32 մլն
-38,82 մլն
-46,11 մլն
-52,69 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-34,75 մլն
-35,96 մլն
-43,32 մլն
-49,89 մլն
EBT excluding unusual items
-34,98 մլն
-35,54 մլն
-43,32 մլն
-49,89 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-34,75 մլն
-35,96 մլն
-43,32 մլն
-49,89 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,83
-0,78
-0,96
-1,05
Interest and investment income
3,34 մլն
3,28 մլն
2,79 մլն
2,80 մլն
Interest expense
-
-
-
-
Net interest expenses
3,34 մլն
3,28 մլն
2,79 մլն
2,80 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps